Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.

التفاصيل البيبلوغرافية
العنوان: Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.
المؤلفون: Knörr F; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg. f.knoerr@uke.de., Schellekens KPJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Schoot RA; Princess Máxima Center for Pediatric Oncology, Utrecht., Landman-Parker J; Pediatric Hematology, Immunology, Oncology, Sorbonne université, Hôpital Armand Trousseau, APHP, Paris., Teltschik HM; Pediatrics 5 (Oncology, Hematology, and Immunology), Olgahospital, Stuttgart., Förster J; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Riquelme A; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Dept. Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Dept. Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht., Van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht., Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam., Woessmann W; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg., Van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht.
المصدر: Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1442-1446. Date of Electronic Publication: 2023 May 01.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
أسماء مطبوعة: Publication: 1999- : Pavia, Italy : Ferrata Storti Foundation
Original Publication: Pavia [etc.]
مواضيع طبية MeSH: Vinblastine* , Lymphoma, Large-Cell, Anaplastic*/pathology, Child ; Humans ; Crizotinib ; Receptor Protein-Tyrosine Kinases ; Anaplastic Lymphoma Kinase
References: J Clin Oncol. 2011 Aug 1;29(22):3065-71. (PMID: 21709186)
J Clin Oncol. 2009 Oct 20;27(30):5056-61. (PMID: 19738127)
J Clin Oncol. 2012 Apr 20;30(12):1358-63. (PMID: 22393086)
J Clin Oncol. 2020 Dec 1;38(34):3999-4009. (PMID: 32730187)
J Clin Oncol. 2017 Oct 1;35(28):3215-3221. (PMID: 28787259)
Stat Med. 1998 May 30;17(10):1103-20. (PMID: 9618772)
Br J Haematol. 2006 Apr;133(2):176-82. (PMID: 16611309)
Pediatr Blood Cancer. 2018 Jun;65(6):e27003. (PMID: 29512859)
Cancer Res. 1993 Nov 1;53(21):5121-6. (PMID: 8221648)
Lancet Oncol. 2013 May;14(6):472-80. (PMID: 23598171)
J Natl Cancer Inst. 2014 Feb;106(2):djt378. (PMID: 24491302)
Cancers (Basel). 2021 Sep 01;13(17):. (PMID: 34503232)
Drug Metab Dispos. 2013 Feb;41(2):343-52. (PMID: 23129213)
Cancer Chemother Pharmacol. 2020 Dec;86(6):829-840. (PMID: 33095287)
J Pediatr Pharmacol Ther. 2021;26(6):647-654. (PMID: 34421417)
معلومات مُعتمدة: 25642 United Kingdom CRUK_ Cancer Research UK
المشرفين على المادة: 53AH36668S (Crizotinib)
5V9KLZ54CY (Vinblastine)
EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)
EC 2.7.10.1 (Anaplastic Lymphoma Kinase)
تواريخ الأحداث: Date Created: 20221215 Date Completed: 20230503 Latest Revision: 20240320
رمز التحديث: 20240320
مُعرف محوري في PubMed: PMC10153539
DOI: 10.3324/haematol.2022.281896
PMID: 36519329
قاعدة البيانات: MEDLINE
الوصف
تدمد:1592-8721
DOI:10.3324/haematol.2022.281896